RE: Poker14 Aug 2018 17:52
I would have ordinarily said that another bid appears likely, given the recent price crash and the fact that there are a few potential buyers floating around out there. However, Spire recently turned down a bid because it 'undervalued the company'. What chance do we have of a bidder coming in with a higher offer now that the share price is in the toilet, compared to where it was at the time of the last bid?
Would the Board have to reevaluate what 'fair value' looks like, or will it just deter a bidder from having a go? It isn't as clear cut as the first time around, when plenty of us predicted a Mediclinic bid was coming in and were able to time our trades accordingly.
My buy-in this time around wasn't based on the expectation of a takeover bid in the near-term. I now see it as a 'buy and hold because I think the share has been oversold' - any M&A activity would just be a bonus.